Prospective Real-World Study of HAIC With Raltitrexed or 5-Fluorouracil for the Treatment of Hepatocellular Carcinoma

This real-world study is tracking outcomes in people with liver cancer (hepatocellular carcinoma) who are receiving a type of chemotherapy delivered directly to the liver through the blood vessels (called HAIC, using either raltitrexed or 5-fluorouracil), to understand how well it works in everyday clinical practice. **You may be eligible if...** - You have been diagnosed with liver cancer (hepatocellular carcinoma) - You are receiving HAIC treatment as part of your standard care - You are willing to have your data and outcomes tracked **You may NOT be eligible if...** - You have significant fluid buildup in the chest, abdomen, or around the heart requiring repeated drainage - You have HIV, have had an organ transplant, or have had a bone marrow transplant - You have serious heart or blood vessel disease - You had a gastrointestinal bleed in the past 6 months - You have a severe active infection - You have another active cancer - You are pregnant Talk to your doctor to see if this trial is right for you.